Ex Parte Ito et alDownload PDFPatent Trial and Appeal BoardJun 9, 201613145348 (P.T.A.B. Jun. 9, 2016) Copy Citation UNITED STA TES p A TENT AND TRADEMARK OFFICE APPLICATION NO. FILING DATE FIRST NAMED INVENTOR 13/145,348 07/20/2011 Hirotaka Ito 22850 7590 06/13/2016 OBLON, MCCLELLAND, MAIER & NEUSTADT, LLP, 1940 DUKE STREET ALEXANDRIA, VA 22314 UNITED STATES DEPARTMENT OF COMMERCE United States Patent and Trademark Office Address: COMMISSIONER FOR PATENTS P.O. Box 1450 Alexandria, Virginia 22313-1450 www .uspto.gov ATTORNEY DOCKET NO. CONFIRMATION NO. 383527US41PCT 4434 EXAMINER BURKHART, ELIZABETH A ART UNIT PAPER NUMBER 1715 NOTIFICATION DATE DELIVERY MODE 06/13/2016 ELECTRONIC Please find below and/or attached an Office communication concerning this application or proceeding. The time period for reply, if any, is set in the attached communication. Notice of the Office communication was sent electronically on above-indicated "Notification Date" to the following e-mail address( es): patentdocket@oblon.com oblonpat@oblon.com ahudgens@oblon.com PTOL-90A (Rev. 04/07) UNITED STATES PATENT AND TRADEMARK OFFICE BEFORE THE PATENT TRIAL AND APPEAL BOARD Ex parte HIROTAKA ITO and KENJI YAMAMOT0 1 Appeal2014-004658 Application 13/145,348 Technology Center 1700 Before JAMES C. HOUSEL, CHRISTOPHER C. KENNEDY, and JENNIFER R. GUPTA, Administrative Patent Judges. KENNEDY, Administrative Patent Judge. DECISION ON APPEAL This is an appeal under 35 U.S.C. § 134(a) from the Examiner's decision to reject claims 1--4 and 6-11. An oral hearing was held on June 7, 2016. We have jurisdiction under 35 U.S.C. § 6(b). We AFFIRM. BACKGROUND The subject matter on appeal relates to a method for producing a diamond-like carbon ("DLC") film. E.g., Spec. ,-i l; Claim 1. Claim 1 is reproduced below from page 14 (Claims Appendix) of the Appeal Brief: 1 According to the Appellants, the Real Party in Interest is KABUSHIKI KASISHA KOBE SEIKO SHO (KOBE STEEL, LTD.). App. Br. 2. Appeal2014-004658 Application 13/145,348 1. A method for producing a diamond-like carbon film, the method comprising the step of forming a diamond-like carbon film on or above a substrate by plasma chemical vapor deposition, wherein the step of forming the diamond-like carbon film includes: applying a bipolar pulsed direct-current voltage to the substrate; feeding a gas containing toluene into a chamber; controlling a total gas pressure in the chamber at 4 Pa or more and 7 Pa or less; and controlling a negative bias voltage in the bipolar pulsed direct- current voltage to have a magnitude of 400 V or more and 650 V or less. REJECTIONS ON APPEAL 1. Claims 1 and 4 stand rejected under 35 U.S.C. § 103(a) as unpatentable over Dekempeneer et al. (EP 0 962 550 Al, published Dec. 8, 1999). 2. Claims 2 and 9 stand rejected under 35 U.S.C. § 103(a) as unpatentable over Dekempeneer in view of Saito et al. (US 2006/003 5083 Al, published Feb. 16, 2006) ("Saito '083"). 3. Claim 3 stands rejected under 35 U.S.C. § 103(a) as unpatentable over Dekempeneer in view of Beck et al. (US 2005/0011748 Al, published Jan. 20, 2005). 4. Claims 10 and 11 stand rejected under 35 U.S.C. § 103(a) as unpatentable over Dekempeneer in view of Beck, further in view of Imoto et al. (JP 2002-363747, published Dec. 18, 2002). 5. Claims 6 and 7 stand rejected under 35 U.S.C. § 103(a) as unpatentable over Dekempeneer in view of Akari et al. (US 2007 /0054125 A 1, published Mar. 8, 2007). 2 Appeal2014-004658 Application 13/145,348 6. Claim 8 stands rejected under 35 U.S.C. § 103(a) as unpatentable over Dekempeneer in view of Saito et al. (US 2007 /0175587 Al, published Aug. 2, 2007) ("Saito '587"). ANALYSIS The Appellants present separate arguments only as to claims 1, 2, and 8. We limit our discussion to those claims. Claims 3, 4, 6, 7, 10, and 11 depend, directly or indirectly, from claim 1, and will therefore stand or fall with claim 1. Claim 9 depends from claim 2 and will therefore stand or fall with claim 2. After review of the cited evidence in the appeal record and the opposing positions of the Appellants and the Examiner, we determine that the Appellants have not identified reversible error in the Examiner's rejections. Accordingly, we affirm the rejections for reasons set forth below and in the Examiner's Answer. See generally Ans. 2-9. Claim 1 The Examiner finds that Dekempeneer teaches a method for producing a DLC film comprising each element of claim 1 except that Dekempeneer discloses pressure and negative bias voltage magnitude ranges that fully encompass, but are broader than, those disclosed by claim 1. Ans. 2. Specifically, the Examiner finds, and the Appellants do not dispute, that Dekempeneer teaches a pressure range of 1-1000 Pa and a negative bias voltage magnitude range of 50-1500. Id. (citing Dekempeneer ,-i 11 (pressure), ,-i 17 (negative bias voltage magnitude)). The Examiner concludes that claim 1 would have been prima facie obvious in view of the overlapping ranges. Ans. 2-3. 3 Appeal2014-004658 Application 13/145,348 Relying on data in their Specification showing deposition rates in the claimed pressure range of 4-7 Pa, Spec. iJ 21, the Appellants argue that the claimed pressure range is "critical," and that the alleged showing of criticality rebuts the prima facie case of obviousness set forth by the Examiner. App. Br. 5-9. They also argue that "Dekempeneer fails to identify the total gas pressure in the chamber as a result-effective variable with respect to the growth rate, much less a high deposition rate in which the plasma is stable," and that "it would not be routine experimentation to reach the claimed method." Id. at 8. We are not persuaded by the Appellants' arguments. As the Federal Circuit explained in In re Geisler, [ w ]hen an applicant seeks to overcome a prima facie case of obviousness by showing improved performance in a range that is within or overlaps with a range disclosed in the prior art, the applicant must show that the claimed range is critical, generally by showing that the claimed range achieves unexpected results relative to the prior art range. Under that standard, it is not inventive to discover the optimum or workable ranges by routine experimentation. Only if the results of optimizing a variable are unexpectedly good can a patent be obtained for the claimed critical range. 116 F.3d 1465, 1469-70 (Fed. Cir. 1997) (internal quotation marks, citations, and alterations omitted; emphases added); see also In re Applied Materials, Inc., 692 F.3d 1289, 1297 (Fed. Cir. 2012) ("The outcome of optimizing a result-effective variable may still be patentable if the claimed ranges are critical and produce a new and unexpected result which is different in kind and not merely in degree from the results of the prior art." (internal quotation marks omitted; emphasis added)); Iron Grip Barbell Co. v. USA Sports, Inc., 392 F.3d 1317, 1322-23 (Fed. Cir. 2004) ("[E]ven 4 Appeal2014-004658 Application 13/145,348 though a modification results in great improvement and utility over the prior art, it may still not be patentable if the modification was within the capabilities of one skilled in the art, unless the claimed ranges produce a new and unexpected result which is different in kind and not merely in degree from the results of the prior art." (internal quotation marks and alterations omitted)). The Appellants argue only that the claimed range is "critical" because it yields improved results. See App. Br. 5-9. They make no argument that the results achieved using the claimed pressure range would have been unexpected, or that the results are "different in kind and not merely in degree from the results of the prior art." See Applied Materials, 692 F.3d at 1297. The Appellants' Specification discloses what is logically described as routine experimentation in which known result-effective variables are optimized to achieve a desirable deposition rate. E.g., Spec. iii! 21, 3 6 (Table 1 ). The type of experimentation described by the Specification is routine experimentation that is well within the ordinary level of skill in the art. The Appellants have made no persuasive argument to the contrary. Dekempeneer expressly teaches that "gas pressure during the deposition" is a "critical parameter[]," Dekempeneer iJ 19, and it teaches that pressure can be varied "between 1 and 1000 Pa and ... preferably between 10 and 50 Pa," Dekempeneer iJ 11, to achieve desired results. Dekempeneer also teaches that "gas pressure influences ... ion energy," which relates to "accelerat[ion] ... for the ions towards the substrate." Id. iii! 21, 22. In particular, Dekempeneer teaches that higher pressure results in reduced ion energy. Id. iJ 22. Moreover, Dekempeneer teaches that "pulse frequency" is a critical parameter, and that "[a] higher frequency allows higher growth 5 Appeal2014-004658 Application 13/145,348 rates to be achieved at comparable process pressures .... " Id. iJ 20. That teaching is similar to the disclosure in the Appellants' Specification concerning frequency and growth rate. See Spec. iii! 4 7 (Table 3), 48 ("[T]he deposition rate increases with an increasing pulse frequency .... "). In view of those teachings, a person of ordinary skill in the art would have understood that pressure is a "critical parameter" to achieving desired deposition characteristics. And, despite the fact that Dekempeneer does not explicitly correlate gas pressure with deposition rate, see App. Br. 8, a person of ordinary skill in the art would have understood Dekempeneer generally to be concerned with, inter alia, "achiev[ing]" "higher growth rates" by optimization of the disclosed "critical parameters." Dekempeneer iii! 19, 20. The Appellants' discussion of Dekempeneer' s Example 1, which uses methane at a pressure of 10 Pa, Dekempeneer iJ 26, is not persuasive. See App. Br. 8-9. "[A] reference is not limited to the disclosure of specific working examples." In re Mills, 470 F.2d 649, 651(CCPA1972). If anything, Example l's disclosure of a pressure of 10 Pa would have suggested to a person of ordinary skill in the art that lower pressures within the disclosed range of 1 to 1000 Pa may be desirable. That Dekempeneer does not explicitly discuss optimization of gas pressure specifically to achieve higher growth rates, see App. Br. 8, does not negate the foregoing analysis or otherwise persuasively show that the claimed pressure range would not have been obvious in view of Dekempeneer' s disclosures. Cf In re Beattie, 974 F.2d 1309, 1312 (Fed. Cir. 1992) ("[T]he law does not require that the references be combined for the reasons contemplated by the inventor."). The Appellants have not persuasively argued that it would have 6 Appeal2014-004658 Application 13/145,348 been beyond the level of ordinary skill in the art to optimize the critical parameters identified by Dekempeneer to achieve a pressure in the range of 4-7 Pa. In the absence of a showing of unexpected results, we are not persuaded that the claimed pressure range, which is fully encompassed by a range disclosed in the prior art, imparts patentable distinction to claim 1. See Geisler, 116 F.3d at 1469-70. Accordingly, we affirm the Examiner's rejection of claim 1. Claim 2 Claim 2 depends from claim 1 and further recites "wherein the gas to be fed into the chamber is a gaseous mixture of toluene and argon, and the gaseous mixture has a volume fraction of toluene of 40% or more." The Examiner finds that Dekempeneer "discloses a gaseous mixture of toluene and argon ... but does not disclose that the gaseous mixture has a volume fraction of toluene of 40% or more and 60% or less." Ans. 3. The Examiner finds that Saito '083 "discloses forming a DLC film on a substrate by PECVD ... wherein a gaseous mixture of toluene and argon may be used .... The amount of toluene used in the mixture may be 2-80 vol% .... " Id. The Examiner concludes that "[i]t would have been obvious ... to include argon in the amount suggested by [Saito '083] with the toluene of Dekempeneer since it was a suitable amount to provide as a dilution gas for forming DLC by PECVD." Id. at 3--4. The Appellants argue that the claimed toluene volume fraction of 40% or more is "critical" to ensure a high deposition rate. App. Br. 10. We are not persuaded by the Appellants' criticality argument for the reasons discussed above. The Appellants do not argue that the claimed 7 Appeal2014-004658 Application 13/145,348 toluene volume fraction yields unexpected results, or that the experimentation and optimization leading to the selection of such a volume fraction would have been beyond the ordinary level of skill in the art. The volume fraction disclosed by Saito '083 substantially overlaps the claimed fraction (and fully encompasses the fraction of claim 9, which depends from claim 2). On this record, we are not persuaded that it would have been beyond the ordinary level of skill in the art to optimize the fraction, including to the volume fraction recited by claim 2, to obtain desirable deposition characteristics. Claim 8 Claim 8 depends from claim 1 and further recites "wherein the diamond-like carbon film is formed at a deposition rate of more than 10 micrometers per hour (µm/h)." The Examiner finds that Dekempeneer does not disclose the claimed deposition rate, but that Saito '587 "discloses forming DLC film using pulsed plasma wherein deposition rate may be improved and increased by adjusting the duty ratio .... " Ans. 6. Saito '587 teaches that duty ratio relates to pulse frequency and voltage. E.g., Saito '587 iii! 70-76. The Examiner concludes that "[i]t would have been obvious to one of ordinary skill in the art ... to adjust the duty ratio as suggested by [Saito '587] in the process of Dekempeneer in order to increase and improve the deposition rate of the DLC film, including values within the claimed range." Ans. 6. In response to the Appellants' arguments, the Examiner further finds that "the deposition rate is an inherent result of using toluene." Id. at 8-9. The Appellants argue that "none of [Saito '587's] experiments produced a film forming rate which is more than 10 µm/h. . . . Thus, 8 Appeal2014-004658 Application 13/145,348 Saito '587 fails to disclose or suggest that the diamond-like carbon film is formed at a deposition rate of more than 10 µm/h." App. Br. 12. They further argue that "Dekempeneer and Saito '587 fail to recognize the criticality of the required range of the total gas pressure in the chamber for achieving a high deposition rate of more than 10 µm/h in which the plasma is stable." Id. While we agree with the Appellants that "a deposition rate of more than 10 micrometers per hour is not an inherent result of using toluene," Reply Br. 6, we are not persuaded of reversible error in the Examiner's rejection. In particular, as set forth above, Dekempeneer renders obvious the method of claim 1, from which claim 8 depends. Dekempeneer teaches not only the use of toluene, but also the use of pressures and negative bias voltage amplitudes that encompass those of claim 1. Dekempeneer ,-i,-i 19-22. Dekempeneer also teaches the use of higher pulse frequencies to achieve higher growth rates. Id. ,-i 20. That teaching is consistent with Saito '587's teachings concerning duty ratio and growth rate. Saito '587,-i,-i 70-76. While growth rates of more than 10 µm/h do not appear to be an inherent result of using toluene in and of itself, Dekempeneer appears to teach or otherwise render obvious deposition conditions (including the use of toluene) that would inherently produce the claimed growth rate. An obvious method does not become nonobvious merely by claiming an inherent result of practicing the method. Cf Bristol-Myers Squibb Co. v. Ben Venue Labs., Inc., 246 F.3d 1368, 1376 (Fed. Cir. 2001) ("Newly discovered results of known processes directed to the same purpose are not patentable because such results are inherent."); cf also Santarus, Inc. v. Par Pharm., Inc., 694 F.3d 1344, 1354 (Fed. Cir. 2012) (obvious pharmaceutical 9 Appeal2014-004658 Application 13/145,348 formulation does not "become patentable merely by testing and claiming an inherent property" of the formulation). On this record, we are not persuaded of reversible error in the Examiner's rejection of claim 8. CONCLUSION We AFFIRM the Examiner's rejection of claims 1--4 and 6-11. No time period for taking any subsequent action in connection with this appeal may be extended under 37 C.F.R. § l.136(a). AFFIRMED 10 Copy with citationCopy as parenthetical citation